This content is machine translated Epilepsy Cannabidiol for refractory epilepsy syndromes The pharmaceutical formulation of high-purity cannabidiol is approved for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. Despite many years of clinical experience, there...…
View Post 3 min This content is machine translated Lennox-Gastaut syndrome Unmet need with a significant burden of disease New data presented at the 15th European Epilepsy Congress show long delays in the diagnosis of Lennox-Gastaut syndrome (LGS) in Europe and a significant burden of disease due to seizure…
View Post 3 min This content is machine translated Epilepsy in childhood Modern therapy management is more than just seizure control Lennox-Gastaut syndrome and Dravet syndrome are rare and severe developmental and epileptic encephalopathies with onset in infancy or early childhood. In addition to the seizures, comorbidities often occur, which represent…
View Post 3 min This content is machine translated Epilepsy in pediatrics On the way to improving quality of life with cannabidiol Plant-derived, highly purified cannabidiol reduces the frequency of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome and improves the overall condition of patients in placebo-controlled Phase III studies of the……
